96 related articles for article (PubMed ID: 25440855)
1. Burns and epilepsy--review and case report.
Gragnani A; Müller BR; Oliveira AF; Ferreira LM
Burns; 2015 Mar; 41(2):e15-8. PubMed ID: 25440855
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical seizures in phenytoin toxicity.
Chua HC; Venketasubramanian N; Tan CB; Tjia H
Singapore Med J; 1999 Apr; 40(4):276-7. PubMed ID: 10487084
[TBL] [Abstract][Full Text] [Related]
3. Phenytoin pharmacokinetics in burned rats and plasma protein binding of phenytoin in burned patients.
Bowdle TA; Neal GD; Levy RH; Heimbach DM
J Pharmacol Exp Ther; 1980 Apr; 213(1):97-9. PubMed ID: 7359372
[TBL] [Abstract][Full Text] [Related]
4. Use of phenytoin serum levels in a case of status epilepticus.
Fincham RW; Wiley DE; Schottelius DD
Neurology; 1976 Sep; 26(9):879-81. PubMed ID: 986031
[TBL] [Abstract][Full Text] [Related]
5. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.
Blanchet B; Jullien V; Vinsonneau C; Tod M
Clin Pharmacokinet; 2008; 47(10):635-54. PubMed ID: 18783295
[TBL] [Abstract][Full Text] [Related]
6. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
7. Daily salivary anticonvulsant monitoring in patients with intractable epilepsy.
Herkes GK; Eadie MJ
Clin Exp Neurol; 1989; 26():141-9. PubMed ID: 2642124
[TBL] [Abstract][Full Text] [Related]
8. Steady-state anticonvulsant drug levels in epileptic patients.
Kokwaro GO; Kwasa TO; Indalo AA; Kibwage IO
East Afr Med J; 1996 Oct; 73(10):679-82. PubMed ID: 8997850
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance.
Kousar S; Wafai ZA; Wani MA; Jan TR; Andrabi KI
Int J Clin Pharmacol Ther; 2015 Jul; 53(7):504-16. PubMed ID: 25943175
[TBL] [Abstract][Full Text] [Related]
10. Contraception, pregnancy and lactation in women with epilepsy.
Yerby MS
Baillieres Clin Neurol; 1996 Dec; 5(4):887-908. PubMed ID: 9068887
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats.
Reeta KH; Mehla J; Pahuja M; Gupta YK
Pharmacol Biochem Behav; 2011 Sep; 99(3):399-407. PubMed ID: 21641922
[TBL] [Abstract][Full Text] [Related]
12. Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats.
Löscher W; Rundfeldt C
J Pharmacol Exp Ther; 1991 Aug; 258(2):483-9. PubMed ID: 1650829
[TBL] [Abstract][Full Text] [Related]
13. Estimation of population pharmacokinetic parameters of free-phenytoin in adult epileptic patients.
Deleu D; Aarons L; Ahmed IA
Arch Med Res; 2005; 36(1):49-53. PubMed ID: 15777995
[TBL] [Abstract][Full Text] [Related]
14. Phenytoin and phenobarbital protein binding alterations in a uremic burn patient.
Pugh CB
Drug Intell Clin Pharm; 1987 Mar; 21(3):264-7. PubMed ID: 3569025
[TBL] [Abstract][Full Text] [Related]
15. Lack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsy.
Levy RH; Ragueneau-Majlessi I; Garnett WR; Schmerler M; Rosenfeld W; Shah J; Pan WJ
J Clin Pharmacol; 2004 Nov; 44(11):1230-4. PubMed ID: 15496640
[TBL] [Abstract][Full Text] [Related]
16. Phenytoin-rifampin drug interaction in a hypoalbuminemic, renal failure patient: a complex clinical case.
Van Berkel MA; Hurdle AC; Twilla JD
Pharmacotherapy; 2013 Jun; 33(6):e96-100. PubMed ID: 23471818
[TBL] [Abstract][Full Text] [Related]
17. Practical considerations in anticonvulsant therapy--Part 2.
Meyer MC; Cloyd J; Garnett WR; Holmes GL; Schiffer JR
Am Pharm; 1995 Sep; NS35(9):31-6, 40. PubMed ID: 7484814
[TBL] [Abstract][Full Text] [Related]
18. COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats.
van Vliet EA; Zibell G; Pekcec A; Schlichtiger J; Edelbroek PM; Holtman L; Aronica E; Gorter JA; Potschka H
Neuropharmacology; 2010 Feb; 58(2):404-12. PubMed ID: 19786037
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study.
Ebid AH; Ahmed MM; Mohammed SA
Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887
[TBL] [Abstract][Full Text] [Related]
20. Study on delay two-phase multiple organ dysfunction syndrome.
Hu S; Sheng Z; Zhou B; Guo Z; Lu J; Xue L; Jin H; Sun X; Sun S; Li J; Lü Y
Chin Med J (Engl); 1998 Feb; 111(2):101-8. PubMed ID: 10374366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
